Cargando…
The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience
BACKGROUND: In this single-center study, we evaluated efficacy and safety issues and predictors of survival in patients with idiopathic and congenital heart disease-associated pulmonary arterial hypertension who were under macitentan therapies. METHOD: Our study retrospectively evaluated 221 patient...
Autores principales: | Kaymaz, Cihangir, Tanyeri, Seda, Ceren Tokgöz, Hacer, Yaşar Akbal, Özgür, Karagöz, Ali, Keskin, Berhan, Kültürsay, Barkın, Hakgör, Aykun, Külahçıoğlu, Şeyhmus, Bayram, Zübeyde, Çağan Efe, Süleyman, Halil Tanboğa, İbrahim, Doğan, Cem, Akbulut, Mehmet, Özdemir, Nihal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623128/ https://www.ncbi.nlm.nih.gov/pubmed/36196862 http://dx.doi.org/10.5152/AnatolJCardiol.2022.1889 |
Ejemplares similares
-
Clinical, imaging and hemodynamic correlates and prognostic impact of syncope in acute pulmonary embolism: A single-center study
por: Keskin, Berhan, et al.
Publicado: (2022) -
Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Arterial Hypertension: A Single-Center Experience and Review of Current Literature
por: Ceren Tokgöz, Hacer, et al.
Publicado: (2022) -
Reappraisal of the Transthoracic Echocardiographic Algorithm in Predicting Pulmonary Hypertension Redefined by Updated Pulmonary Artery Mean Pressure Threshold
por: Tanyeri, Seda, et al.
Publicado: (2023) -
A Novel Composed Index to Evaluate the Right Ventricle Free-Wall Adaptation Against Ventricular Wall Stress in Acute Pulmonary Embolism
por: Hakgör, Aykun, et al.
Publicado: (2023) -
Eosinophil-to-Monocyte Ratio as a Candidate for a Novel Prognostic Marker in Acute Pulmonary Embolism: Is it a Consumptive Mechanism?
por: Külahçıoğlu, Şeyhmus, et al.
Publicado: (2022)